glycostem.com

Innovative Cellular Cancer Therapy with stem cell derived natural killer NK cells - Glycostem

Taking cellular immunotherapy to the next level. Glycostem is an innovator in allogeneic cellular immunotherapy using Natural Killer (NK) cells - oNKord. Or antigen presenting cells - sDCord. For treatment of leukemia, lymphoma and solid tumors. Check out the team that is operating at the cutting edge of immunotherapy. The ability to make cancer a chronic disease. ONKord is our lead candidate but we are working on more products. Our mould-breaking and loyal supporters. View our job opportunities.

http://www.glycostem.com/

OVERVIEW OF glycostem.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

8

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR GLYCOSTEM.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.2 out of 5 with 13 reviews

5 star

9

4 star

2

3 star

0

2 star

0

1 star

2

Hey there! Start your review of glycostem.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1.1 seconds

FAVICON PREVIEW

16x16
32x32
64x64
128x128
160x160
192x192
256x256

CONTACTS AT GLYCOSTEM.COM

Glycostem Therapeutics Corporate

Dirk Groenewegen

Onderwi●●●●●●●ard 219

Den●●●sch , 5203 DB

NL

31.7●●●●4520

in●●@glycostem.com

View this contact

Glycostem Therapeutics Corporate

Dirk Groenewegen

Onderwi●●●●●●●ard 219

Den●●●sch , 5203 DB

NL

31.7●●●●4520

in●●@glycostem.com

View this contact

Glycostem Therapeutics Corporate

Dirk Groenewegen

Onderwi●●●●●●●ard 219

Den●●●sch , 5203 DB

NL

31.7●●●●4520

in●●@glycostem.com

View this contact

Simplefly

Amanuel Flobbe

Vonde●●●●●n 80

UT●●HT , 3521 GH

NL

31.3●●●●9717

in●●@simplefly.nl

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2002 May 15
UPDATED: 2014 June 19
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

22

YEARS
0

MONTHS
20

DAYS

NAME SERVERS

1: dns1.hosted.nl
2: dns2.hosted.nl
3: dns3.hosted.nl

REGISTRAR

KEY-SYSTEMS GMBH

WHOIS : whois.rrpproxy.net

REFERRED : http://www.key-systems.net

CONTENT

PAGES IN
THIS WEBSITE

8

SSL

EXTERNAL LINKS

4

SITE IP

178.18.89.77

LOAD TIME

1.058 sec

SCORE

6.2

PAGE TITLE

Innovative Cellular Cancer Therapy with stem cell derived natural killer NK cells - Glycostem | glycostem.com Reviews

<META> DESCRIPTION

Taking cellular immunotherapy to the next level. Glycostem is an innovator in allogeneic cellular immunotherapy using Natural Killer (NK) cells - oNKord. Or antigen presenting cells - sDCord. For treatment of leukemia, lymphoma and solid tumors. Check out the team that is operating at the cutting edge of immunotherapy. The ability to make cancer a chronic disease. ONKord is our lead candidate but we are working on more products. Our mould-breaking and loyal supporters. View our job opportunities.

<META> KEYWORDS

1 patients

2 investors

3 news

4 about us

5 technology

6 find out more

7 publications

8 disclaimer

9 europe

10 north america

CONTENT

Page content here

KEYWORDS ON PAGE

patients,investors,news,about us,technology,find out more,publications,disclaimer,europe,north america,south america,asia,africa,oceania,area of interest,scientific,commercial,clinical,patient,media,investor

SERVER

Apache

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Innovative Cellular Cancer Therapy with stem cell derived natural killer NK cells - Glycostem | glycostem.com Reviews

https://glycostem.com

Taking cellular immunotherapy to the next level. Glycostem is an innovator in allogeneic cellular immunotherapy using Natural Killer (NK) cells - oNKord. Or antigen presenting cells - sDCord. For treatment of leukemia, lymphoma and solid tumors. Check out the team that is operating at the cutting edge of immunotherapy. The ability to make cancer a chronic disease. ONKord is our lead candidate but we are working on more products. Our mould-breaking and loyal supporters. View our job opportunities.

INTERNAL PAGES

glycostem.com

1

Investors - Glycostem

http://glycostem.com/investors

Glycostem Therapeutics developed the world's first GMP compliant manufacturing platform ready for industrial scale-up, providing allogeneic cells for cancer immunotherapy. To further advance the lead in allogeneic cell therapy using oNKord or sDCord , Glycostem initiated a Series A financing round to realize the following plans:. Preparation and execution of an oNKord pivotal phase II study in AML. Boosting clinical development in other indications. For more information please contact us.

2

News - Glycostem

http://glycostem.com/news

Annual Discovery on Target Event, Boston. September 19-22, 2016. June 27-28, 2016. BIO International Convention San Francisco. June 6-9, 2016. Health Valley Event, Pivot Park Oss. June 2, 2016. May 16-18, 2016. Orphan-Drug Designation request of NK Cell Product oNKord granted by FDA. April 20, 2016. March 1-3, 2016. Biotech Showcase San Francisco. Jan 11-13, 2016. December 4-8, 2015. November 2-4, 2015. Natural Killer Cell Symposium. October 7-9, 2016. September 29-30, 2015. July 9, 2015. May 2-6, 2015.

3

Products - Glycostem

http://glycostem.com/products

Glycostem’s production technology platform allows for a multitude of off-the-shelf products. Glycostem invents novel treatment options of hematological indications and solid tumors with the company's first-generation cell therapy products - oNKord. Glycostem is using further the full potential of its platform technology and derived products by developing multidimensional products and therapies:. NK cells and therapeutic antibodies. ONKord phase I study. For more information please contact us.

4

Disclaimer - Glycostem

http://glycostem.com/disclaimer

Through this website you are able to link to other websites which are not under the control of Glycostem Therapeutics. We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them. For more information please contact us.

5

About us - Glycostem

http://glycostem.com/about-us

Fighting cancer with cellular immunotherapy. Glycostem Therapeutics is a biotechnological life science company, based in Oss, the Netherlands. Our ultimate objective is to effectively target terminal cancer to enable curative treatment approaches. Most of the current cancer treatments do not (entirely) solve this fundamental problem. We believe that cellular therapy’s current breakthroughs are marking a paradigm shift in the way cancer will be treated in the near future.

UPGRADE TO PREMIUM TO VIEW 3 MORE

TOTAL PAGES IN THIS WEBSITE

8

LINKS TO THIS WEBSITE

pivotpark.org

De ondernemingen - Life Sciences Community Oss

http://www.pivotpark.org/nl/44/de-ondernemingen

Ondernemers: een brede verscheidenheid. Pivot Park wordt gevormd door een brede verscheidenheid aan starters en reeds bestaande ondernemingen in de verschillende fases van geneesmiddelenontwikkeling:. Aduro Biotech Europe ontwikkelt, in samenwerking met top oncologiecentra in Nederland, antistoffen voor de behandeling van kanker. Het management heeft uitgebreide ervaring met laboratoriumonderzoek van antistoffen die immunologische afstoting van kanker stimuleren en de overlevingskans van kankerpatiën...

pivotpark.com

De ondernemingen - Life Sciences Community Oss

http://www.pivotpark.com/nl/44/de-ondernemingen

Ondernemers: een brede verscheidenheid. Pivot Park wordt gevormd door een brede verscheidenheid aan starters en reeds bestaande ondernemingen in de verschillende fases van geneesmiddelenontwikkeling:. Aduro Biotech Europe ontwikkelt, in samenwerking met top oncologiecentra in Nederland, antistoffen voor de behandeling van kanker. Het management heeft uitgebreide ervaring met laboratoriumonderzoek van antistoffen die immunologische afstoting van kanker stimuleren en de overlevingskans van kankerpatiën...

pivotpark.nl

De ondernemingen - Life Sciences Community Oss

http://www.pivotpark.nl/nl/44/de-ondernemingen

Ondernemers: een brede verscheidenheid. Pivot Park wordt gevormd door een brede verscheidenheid aan starters en reeds bestaande ondernemingen in de verschillende fases van geneesmiddelenontwikkeling:. Aduro Biotech Europe ontwikkelt, in samenwerking met top oncologiecentra in Nederland, antistoffen voor de behandeling van kanker. Het management heeft uitgebreide ervaring met laboratoriumonderzoek van antistoffen die immunologische afstoting van kanker stimuleren en de overlevingskans van kankerpatiën...

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL LINKS TO THIS WEBSITE

4

OTHER SITES

glycospectrumscan.org

豪華胡蝶蘭専門店

販売価格(税込) 22,050 円.

glycosport.com

Glycosport.com is for sale! Click here to inquire.

glycospot.dk

GlycoSpot

Standard CPH substrate kits. Multi CPH substrate kits. A new generation of kits for rapid. GlycoSpot is a company dedicated to revolutionize high-throughput solutions for glycoscience. If you are looking for rapid screening of carbohydrate-modifying enzymes, GlycoSpot has the solution for you. GlycoSpot enzyme screening kits provide high-throughput, reproducible solutions for enzyme screening in a simple 3-step procedure. Results are obtained as a ready-to-read colorimetric output in microwell format.

glycostasis.com

Home

Glycostasis has engineered a human protein to release insulin when blood glucose levels rise and bind it when glucose levels fall, mimicking the natural regulation of insulin in a healthy individual. Dr John Mulligan, Ph.D.

glycostationx.org

The Nomura Institute of Glycosciece Blog | Extended version of The Nomura Lab Web Page at Kyushu University

The Nomura Institute of Glycosciece Blog. Extended version of The Nomura Lab Web Page at Kyushu University. 九州大学の The Nomura Labのホームページ. ConBio2017 ランチョンセミナーの動画が公開されました 2018 3 15. 研究生活における電子学術資料の利活用とメリット – 第1部情報探索とインプットをより効果的に Part 1). 研究生活における電子学術資料の利活用とメリット – 第2部論文執筆やポスター発表に役立てよう Part 2). The Nomura Institute of Glycosciece Blog. Proudly powered by WordPress.

glycostem.com

Innovative Cellular Cancer Therapy with stem cell derived natural killer NK cells - Glycostem

Taking cellular immunotherapy to the next level. Glycostem is an innovator in allogeneic cellular immunotherapy using Natural Killer (NK) cells - oNKord. Or antigen presenting cells - sDCord. For treatment of leukemia, lymphoma and solid tumors. Check out the team that is operating at the cutting edge of immunotherapy. The ability to make cancer a chronic disease. ONKord is our lead candidate but we are working on more products. Our mould-breaking and loyal supporters. View our job opportunities.

glycostemlims.com

Login - LIMS

glycosteve.blogspot.com

GlycoOpt: Opportunities with Glyconutrients

GlycoOpt: Opportunities with Glyconutrients. Glyconutrients are 8 necessary simple sugars called monosaccharides. Glyconutrients have shown to promote cell to cell communication. Discover the importance of these special simple sugars that are missing in today's diet. You can check Google and you'll see what this search engine finds! Get back to me for more information on this exciting discovery. WWW.STEVEBIZ.INFO. Saturday, May 12, 2007. New Book on Glyconutrients. Click here for link. Glyco comes from t...

glycostore.com

glycostory.co.za

Glycostory

Fruit and vegetable consumption is vitally important to sustain health. Most people are not eating enough of these foods, which contain lower amounts of vitamins and minerals today compared to 50 years ago. Dietary supplementation is thus appropriate for most people. Welcome to glycostory.co.za. This web site will contain the personal testimonies of anyone who would like to leave theirs in our guestbook. If you have a story to tell, then please go to our guestbook. I cant afford it! If you've heard any o...

glycostructures.jp

巷で噂のデリヘル体験談